Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia : Journal of Clinical Psychopharmacology

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Letter to the Editors – Research Report

Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia

Okada, Tsuyoshi MD, PhD; Hori, Hikaru MD, PhD; Hasegawa, Naomi PhD; Murata, Atsunobu MS; Kyou, Yoshitaka MD, PhD; Kodaka, Fumitoshi MD, PhD; Iida, Hitoshi MD, PhD; Ochi, Shinichiro MD, PhD; Takaesu, Yoshikazu MD, PhD; Tsuboi, Takashi MD, PhD; Iga, Jun-ichi MD, PhD; Ichihashi, Kayo MD; Muraoka, Hiroyuki MD, PhD; Furihata, Ryuji MD, PhD; Yasui-Furukori, Norio MD, PhD; Usami, Masahide MD, PhD; Onitsuka, Toshiaki MD, PhD; Ogasawara, Kazuyoshi MD, PhD; Tagata, Hiromi MD, PhD; Takeshima, Masahiro MD, PhD; Ohi, Kazutaka MD, PhD; Numata, Shusuke MD, PhD; Hashimoto, Naoki MD, PhD; Yamada, Hiroki MD, PhD; Makinodan, Manabu MD, PhD; Komatsu, Hiroshi MD, PhD; Hishimoto, Akitoyo MD, PhD; Yamagata, Hirotaka MD, PhD; Kido, Mikio MD, PhD; Kubota, Chika MD, PhD; Atake, Kiyokazu MD, PhD; Yamada, Hisashi MD, PhD; Nagasawa, Tatsuya MD, PhD; Matsumoto, Junya MD, PhD; Miura, Kenichiro MD, PhD; Inada, Ken MD, PhD; Watanabe, Koichiro MD, PhD; Suda, Shiro MD, PhD; Hashimoto, Ryota MD, PhD

Author Information
Journal of Clinical Psychopharmacology: 11/12 2022 - Volume 42 - Issue 6 - p 591-593
doi: 10.1097/JCP.0000000000001604
  • Buy
  • SDC
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.